SF-018-5 Erlotinib chemoprevention of hepatocellular carcinoma in a rat model of cirrhosis
スポンサーリンク
概要
- 論文の詳細を見る
- 2010-03-05
著者
-
Yamada Suguru
Div Surgical Oncology Harvard Medical School And Massachusetts General Hospital
-
Fuchs Bryan
Div Surgical Oncology, Harvard Medical School and Massachusetts General Hospital
-
Fujii Tsutomu
Div Surgical Oncology, Harvard Medical School and Massachusetts General Hospital
-
Lauwers Gregory
Dept Pathology, Harvard Medical School and Massachusetts General Hospital
-
McGinn Christopher
Div Thoracic Surgery, Harvard Medical School and Massachusetts General Hospital
-
Kuroda Toshihiko
Div Surgical Oncology, Harvard Medical School and Massachusetts General Hospital
-
Fuchs Bryan
Div Surgical Oncology Harvard Medical School And Massachusetts General Hospital
-
Fujii Tsutomu
Div Surgical Oncology Harvard Medical School And Massachusetts General Hospital
-
Lauwers Gregory
Dept Pathology Harvard Medical School And Massachusetts General Hospital
-
Kuroda Toshihiko
Div Surgical Oncology Harvard Medical School And Massachusetts General Hospital
-
Mcginn Christopher
Div Thoracic Surgery Harvard Medical School And Massachusetts General Hospital
関連論文
- SF-018-1 Enzyme/prodrug cancer therapy mediated by armed oncolytic HSV vectors
- SF-018-5 Erlotinib chemoprevention of hepatocellular carcinoma in a rat model of cirrhosis